TrialNature medicine2014

In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease.

Raja Atreya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.